Latest Breaking News On - Lisa guiterman - Page 3 : comparemela.com

BrainStorm Cell Therapeutics to Present at European Life Sciences CEO Forum

NEW YORK, Feb. 13, 2024 /PRNewswire/ BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that it will provide.

United statesStacy lindborgLisa guitermanChaim lebovitsDrug administrationNeuro advances panelHilton zurich airport hotelEuropean medicines agencyEuropean life sciencesCalifornia institute for regenerative medicineBrainstorm cell therapeutics incNational ms societyPrnewswire brainstorm cell therapeutics incStorm cell therapeuticsAnnual european life sciencesPanorama room

BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS

Meeting Provided a Clear Path for Planned Phase 3b Trial NEW YORK, Dec. 7, 2023 /PRNewswire/ BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for.

United statesChaim lebovitsLisa guitermanJohn mullalyDrug administrationNational ms societyBrainstorm cell therapeutics incEuropean medicines agencyCalifornia institute for regenerative medicineLifesci advisorsPrnewswire brainstorm cell therapeutics incMeeting providedClear pathPlanned phaseStorm cell therapeuticsSpecial protocol assessment

BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS

BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLisa guitermanChaim lebovitsJohn mullalyNational ms societyCalifornia institute for regenerative medicineLifesci advisorsDrug administrationBrainstorm cell therapeutics incEuropean medicines agencyPrnewswire brainstorm cell therapeutics incMeeting providedClear pathPlanned phaseStorm cell therapeuticsSpecial protocol assessment

BrainStorm Cell Therapeutics to Present at 6th Annual ALS Research Symposia

BrainStorm Cell Therapeutics to Present at 6th Annual ALS Research Symposia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of massachusetts medical schoolRobert brownRobert millerMatthew burfordLisa guitermanStacy lindborgJohn mullalyAnthony windebankNamita goyalJames berryJonathan katzBob dagherRobert balohNational ms societyCalifornia pacific medical center prof

BrainStorm Cell Therapeutics Provides Update on FDA Advisory Committee Meeting to Review NurOwn for the Treatment of ALS

/PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today.

United statesJohn mullalyStacy lindborgLisa guitermanChaim lebovitsDrug administration cellularEuropean medicines agencyBrainstorm cell therapeutics incPrnewswire brainstorm cell therapeutics incDrug administrationLifesci advisorsGene therapies advisory committeeNational ms societyCalifornia institute for regenerative medicineAdvisory committeeStorm cell therapeutics